Its probably something more around this GLP-1 receptor recognition, she said
According to the MHRA-approved product information, the most frequently reported adverse effects are gastrointestinal in nature
personal fees from Eli Lilly, Merck, Novo Nordisk, and Intarcia, and grants from Merck, and Ligand outside the submitted work
However, what we know so far is that the greatest utilization of these therapies have been observed in predominantly wealthy communities, which have comparatively lower rates of obesity and associated cardiometabolic conditions. Most of the data on these therapies thus far has been driven by clinical trials, which do not account for disruptions in medication adherence that often occur among everyday people
The dose can be further increased to 1 mg weekly and up to 2 mg weekly if needed for optimal glycaemic control, depending on individual response and tolerability
doi: 10.3109/02699052.2015.1089601